Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 18.
doi: 10.1002/ohn.70066. Online ahead of print.

Pediatric Head and Neck Chordomas: A National Analysis of Prognostic Indicators and Survival Outcomes

Emily A Clementi  1 , Patricia Timothee  2 , Kenechukwu Charles-Obi  3 , Christina Zhu  1 , John S Anderson  1 , Earl H Harley Jr  1   2
Affiliations

Pediatric Head and Neck Chordomas: A National Analysis of Prognostic Indicators and Survival Outcomes

Emily A Clementi et al. Otolaryngol Head Neck Surg. .

Abstract

Objective: To identify prognostic factors among pediatric patients with head and neck chordomas.

Study design: Cross-sectional analysis.

Setting: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 22 database.

Methods: Pediatric patients (<19 years of age) with head and neck chordomas were identified using the SEER database, spanning the years 2000 through 2021. Demographics and clinicopathologic characteristics were assessed using descriptive statistics and stratified by age (<10 years vs ≥10 years). Overall survival (OS) and cancer-specific survival (CSS) were estimated using Kaplan-Meier analysis, and Cox proportional hazards models were used to evaluate the associations with survival.

Results: Among the 141 cases, 57.4% were aged ≥10 years. Age ≥10 years was associated with improved OS and CSS (adjusted HRs 0.26 and 0.14, respectively) Most tumors were conventional chordomas (85.8%) located in the skull base (84.4%). Dedifferentiated and chondroid subtypes were more common in patients <10 and ≥10 years, respectively, and both were associated with significantly worse CSS (adjusted HRs 8.06 and 6.36, respectively). At diagnosis, 41.8% had localized disease, while 9.9% had distant metastases. The most common treatment was surgery with adjuvant radiation (40.7%). Definitive chemotherapy was a risk factor for worse OS (HR 8.99) and CSS (HR 11.67).

Conclusion: Pediatric head and neck chordomas primarily develop at the skull base, with survival outcomes influenced by factors such as age, tumor histology, and treatment approach. Younger age, nonconventional histology, and chemotherapy were associated with poorer prognosis, highlighting the importance of age-appropriate, multidisciplinary management strategies.

Keywords: SEER database; head and neck cancer; pediatric chordoma; pediatric otolaryngology; skull base tumor; survival.

PubMed Disclaimer

References

    1. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12:1‐11.
    1. John L, Smith H, Ilanchezhian M, et al. The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor. Pediatr Blood Cancer. 2023;70:e30358. doi:10.1002/pbc.30358
    1. Chambers KJ, Lin DT, Meier J, Remenschneider A, Herr M, Gray ST. Incidence and survival patterns of cranial chordoma in the United States. Laryngoscope. 2014;124(5):1097‐1102.
    1. Lau CSM, Mahendraraj K, Ward A, Chamberlain RS. Pediatric chordomas: a population‐based clinical outcome study involving 86 patients from the Surveillance, Epidemiology, and End Result (SEER) database (1973‐2011). Pediatr Neurosurg. 2016;51(3):127‐136.
    1. Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol. 2006;30(7):811‐818.

LinkOut - more resources